Xcellerant Ventures

DeepLook Medical develops advanced medical imaging software aimed at enhancing the detection of early breast cancer in mammograms. Utilizing shape-recognition technology, the software extracts and analyzes data from radiological images, particularly focusing on dense breast tissue where critical details may be obscured. By revealing radiomic features that reflect tissue morphology, the software helps physicians identify subtle indicators of breast cancer that are often undetectable by the human eye. This capability not only improves diagnostic accuracy but also reduces the likelihood of unnecessary surgical interventions by minimizing false positives in mammography results. Additionally, DeepLook Medical offers a phenotype database for breast cancer morphology, which is currently available for research purposes.

CRISPRQC develops an analytics platform that enhances the efficiency and effectiveness of CRISPR gene editing. This platform is built around the CRISPR-Chip, a unique device that directly measures CRISPR activity. By simulating the gene editing process prior to cell introduction, CRISPRQC provides essential data and insights that are crucial for quality control and maximizing the potential of CRISPR technology. The platform empowers scientists to increase editing efficiency and formulate strategies for improved outcomes at the cellular level, ultimately accelerating the development of CRISPR-based products.

Lenoss Medical specializes in developing innovative surgical and medical instruments aimed at treating spinal fractures. The company offers the osteopearl VBA system, a minimally invasive and cement-free technology that facilitates the natural healing process of bone. This approach is particularly beneficial for osteoporotic patients, as it leverages the body's inherent healing capabilities while minimizing the risk of complications associated with traditional treatments. By focusing on these advanced solutions, Lenoss Medical aims to improve patient outcomes and enhance the overall treatment landscape for spinal injuries.

TruLite Health operates a health equity platform that aims to bridge the health equity gap, improving patient outcomes and community well-being. Its core offering is an enterprise point-of-care SaaS platform that integrates a proprietary clinical knowledge base with patient-specific clinical and social data. This enables care teams to deliver tailored, actionable clinical, social, and behavioral interventions, catering to diverse patient populations.